AKT answer relating to weight management

Answer D. Orlistat should be discontinued if the patient has failed to lose ≥5% of their body weight over the first 3 months of use

Orlistat can be trialled in primary care where a patient has a BMI ≥30 kg/m², or ≥28 kg/m², with other risk factors including high blood pressure or high cholesterol. Orlistat should be discontinued if the patient has failed to lose ≥5% of their body weight over the first 3 months of use.

InnovAiT article: Gestational diabetes. DOI: 10.1177/17557380231206325.